• «Masks» of CNS demyelinating diseases. Primary lymphoma
• <em>FCGR3A</em> F158V alleles frequency differs in multiple myeloma patients from healthy population
• A Conformal Prediction Approach to Enhance Predictive Accuracy and Confidence in Machine Learning Application in Chronic Diseases
• A Novel JAK2 Fusion in T-Cell Prolymphocytic Leukemia
• A Rare Case of Atrial Septal Mass Secondary to Lymphoma: Case Report and Review of Literature
• A Rare Case of Refractory Nodal Marginal Zone Lymphoma in a Child, Successfully Cured by Allogeneic Stem Cell Transplant: A Case Report
• A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors
• Acute haemostasis with bevacizumab for upper gastrointestinal bleeding secondary to lymphoma
• Advances and challenges in anti-cancer vaccines for multiple myeloma
• AL Amyloidosis
• Artificial intelligence reveals the predictions of hematological indexes in children with acute leukemia
• Association of race/ethnicity and insurance with survival in patients with diffuse large B-cell lymphoma in a large real-world cohort
• At the Cutting Edge: Novel Agents in Hodgkin Lymphoma and the Evolving Role of Radiation Therapy
• Bifidobacterium Bloodstream Infection in a Lymphoma Patient Undergoing Chemotherapy: A Case Study and Implications for Probiotic Use
• Boosting CAR T cells against lymphomas
• Campylobacter jejuni bacteremia in a leukemic child: a nearly missed diagnosis
• Case report: Dual-targeted BCMA and CS1 CAR-T-cell immunotherapy in recurrent and refractory extramedullary multiple myeloma
• Case report: Macrophage activation syndrome in a patient with Kabuki syndrome
• CD19 CAR T cells for B cell malignancies: a systematic review and meta-analysis focused on clinical impacts of CAR structural domains, manufacturing conditions, cellular product, doses, patient's age, and tumor types
• Childhood leukemia prevention within reach
• Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as a conditioning regimen before autologous hematopoietic cell transplantation
• Clinical improvement after removal of hypercalcemia-causing granulomas
• Clinical significance of FLC tests in patients without other evidence of hematologic disorder
• Clinicopathologic Insights and Molecular Oncogenesis: Understanding Epstein-Barr Virus-Induced B-cell Lymphoproliferations
• Clinicopathological diagnosis of Lennert lymphoma: a case report and review of the literature
• Comparisons of treatment outcomes of epcoritamab versus chemoimmunotherapy, polatuzumab-based regimens, tafasitamab-based regimens, or chimeric antigen receptor T-cell therapy, in third-line or later relapsed/refractory large B-cell lymphoma
• Contemporaneous symptom networks analysis in lymphoma patients during chemotherapy: protocol for a single-centre prospective cross-sectional study
• Diagnostic value of serum vascular endothelial growth factor-D in Korean patients with lymphangioleiomyomatosis
• Difficult Removal of a Stuck Chemoport Catheter of a Paediatric Patient in Post-Coronavirus Disease (COVID-19) Era - Management Strategies and Literature Review
• Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib
• Disparities in time to treatment with oral antimyeloma medications
• Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity
• Dysregulated arginine metabolism in precursor B-cell acute lymphoblastic leukemia in children: a metabolomic study
• Efficacy of Combination of Antiviral Therapy With Neutralizing Monoclonal Antibodies for Recurrent Persistent SARS-CoV-2 Pneumonia in Patients With Lymphoma
• Efficacy of escalating therapy with brentuximab vedotin-AVD in advanced stage Hodgkin lymphoma patients with positive interim positron emission tomography after ABVD
• Enhancing diagnostic precision in EBV-related HLH: a multifaceted approach using ¹⁸F-FDG PET/CT and nomogram integration
• Epstein-Barr Virus-Associated Smooth Muscle Tumor After Kidney Transplantation: A French Multicenter Retrospective Study
• Feasibility and safety of transesophageal mediastinal cryobiopsy in the diagnosis of mediastinal pathologies
• Fluid Overload-Associated Large B-Cell Lymphoma with Light Chain Restriction Type Plasma Cell Infiltration: A Case Report
• Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance
• Hodgkin lymphoma - pain at alcohol consumption as the only symptom
• Hypogammaglobulinemia and Infection Events in Patients with Autoimmune Diseases Treated with Rituximab: 10 Years Real-Life Experience
• Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining
• Identify truly high-risk TP53-mutated diffuse large B cell lymphoma patients and explore the underlying biological mechanisms
• Identifying sarcoidosis trends using web search and real-world data in Sweden: a retrospective longitudinal study
• Impact of M-protein detection on the response evaluations of patients undergoing treatment with the IgG-κ monoclonal antibodies daratumumab or isatuximab, and discrepancies between immunofixation electrophoresis (IFE) systems and reagents
• Intestinal Perforation in a Case of Peripheral T Cell Lymphoma after Initiation of Chemotherapy
• Knowledge, skills, and confidence gaps impacting treatment decision making in relapsed/refractory chronic lymphocytic leukemia and mantle cell lymphoma: a quantitative survey study in France, Germany, and the United States
• Liquid biopsy of peripheral blood using mass spectrometry detects primary extramedullary disease in multiple myeloma patients
• LMP1 enhances aerobic glycolysis in natural killer/T cell lymphoma
• Long-term safety and influence on growth in patients receiving sirolimus: a pooled analysis
• Lys-63-specific deubiquitinase BRCC36 enhances the sensitivity of multiple myeloma cells to lenalidomide by inhibiting lysosomal degradation of cereblon
• Mechanistic Understanding of EBV+Lymphoproliferative Disease Development After Transplantation
• MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesis
• Molecular Mechanism of circVRK1 Regulating the Proliferation and Apoptosis of Acute Lymphoblastic Leukemia KOCL44 Cells by Targeting miR-4428
• Multiple myeloma: unplanned diagnostic pathways and association with risk factors and survival - a nationwide register-based cohort study in Denmark
• Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma
• Multisite distribution of fibrillary inclusions in a patient with light chain proximal tubulopathy: A case report
• Multisystem Lymphangioleiomyomatosis
• Myeloma CAR T-cell therapy toxicity timing: What is the right amount of post-treatment monitoring for our patients?
• National retrospective registry survey on the epidemiology of sarcoidosis in Finland 2002-2022
• Navigating Diagnostic and Therapeutic Challenges in Primary Cutaneous Gamma/Delta T-Cell Lymphoma: A Case Study of Fatal Outcomes Within Two Months
• Neurosarcoidosis as a rapidly progressive dementia associated with normal pressure hydrocephalus
• Nitrofurantoin-associated crystalline and granulomatous interstitial nephritis
• No Role for Tandem Autologous Stem Cell Transplantation in Modern Treatment Paradigms for Transplant Eligible Multiple Myeloma
• Non-Hodgkin lymphoma incidence, mortality, and survival trends in Brunei Darussalam from 2011 to 2020
• Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis
• Ovanligt symtom med hög klinisk valör vid Hodgkins lymfom
• Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment
• Policy and perspective on outpatient programs for autologous hematopoietic cell transplantation and immune-effector cell therapy administration
• Posterior reversible encephalopathy syndrome (PRES) in classic Hodgkin's lymphoma, complicated by anthracycline-induced cardiomyopathy
• Predicting progression-free survival from measurable residual disease in chronic lymphocytic leukemia
• Primary Cutaneous CD4+ Small or Medium T-Cell Lymphoproliferative Disorder With Persistent B-Cell Clone: Clinicopathologic Challenge
• Primary Cutaneous Lymphoproliferative Disorders With Dual B-Cell and T-Cell Clonality: Challenge
• Prognosis and immune biomarkers of multiple myeloma
• Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
• Progressive Multifocal Leukoencephalopathy in Myasthenia Gravis With Selective Hypogammaglobulinemia
• Ready, AIM, stop: ibrutinib plus venetoclax in MCL
• Recombinant hirudin and PAR-1 regulate macrophage polarisation status in diffuse large B-cell lymphoma
• Role and timing of chromosome deletions in multiple myeloma
• Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease
• Sarcoidosis with laryngeal and tracheal involvement
• Sarcoidosis: a general overview
• SILICONE FINE-NEEDLE ASPIRATION RETINAL BIOPSY: A Novel Surgical Technique for Vitreoretinal Lymphoma
• Stem cell memory EBV-specific T cells control EBV tumor growth and persist in vivo
• Survival of patients with classical Hodgkin lymphoma in Finland: a national population-based analysis
• Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma
• T-Cell Neoplasms after B-Cell Neoplasms - The Pre-CAR T-Cell Era
• Targeted multiplex validation of CSF proteomic biomarkers: implications for differentiation of PCNSL from tumor-free controls and other brain tumors
• TCP1 expression alters the ferroptosis sensitivity of diffuse large B-cell lymphoma subtypes by stabilising ACSL4 and influences patient prognosis
• Teaching Video NeuroImage: Isolated Presentation of Cavernous Sinus Syndrome From CNS Lymphoma
• The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification
• The occurrence of cytokine release syndrome and its impact on the prognosis of patients with relapsed and refractory multiple myeloma following chimeric antigen receptor T-cell therapy
• The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoprolifera
• Three-year cardiovascular and non-cardiovascular adverse events in patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma treated with Bruton tyrosine kinase inhibitors acalabrutinib or ibrutinib: a real-world analysis
• Time to diagnosis for a rare disease: managing medical uncertainty. A qualitative study
• Time-dependent change of T cell receptor clonality: From large plaque parapsoriasis to early mycosis fungoides
• Transcriptome profiling of pediatric extracranial solid tumors and lymphomas enables rapid low-cost diagnostic classification
• Tumour lysis syndrome
• Waldenström macroglobulinemia: a challenging case treated with anti-CD19 CAR-T cell therapy